Currently predicting for Tue, 28 May 2024

CLVS Predictions History

5 years ago
NameNotImportant predicted that CLVS for 2019-04-22 is going $21.22 (1.63%)

6 years ago
JS predicted that CLVS for 2017-07-12 is going $93.69 (-1.73%)

6 years ago
JS predicted that CLVS for 2017-06-30 is going $91.04 (-2.77%)

6 years ago
bbullish2 predicted that CLVS for 2017-06-30 is going $88.89 (-3.38%)

6 years ago
JS predicted that CLVS for 2017-06-29 is going $94.89 (3.14%)

6 years ago
bbullish2 predicted that CLVS for 2017-06-29 is going $94.36 (0.86%)

6 years ago
bbullish2 predicted that CLVS for 2017-06-08 is going $59.07 (-0.42%)

6 years ago
Mike.Adams.7903 predicted that CLVS for 2017-06-08 is going $62.00 (4.52%)

Rank:

6 years ago
JS predicted that CLVS for 2017-06-08 is going $59.98 (1.11%)

6 years ago
Jon predicted that CLVS for 2017-06-08 is going $55.93 (-5.71%)

Click to get the best stock tips daily for free!

About Clovis Oncology

Clovis Oncology Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer, as well as for metastatic castration-resistant prostate cancer. In Europe, the... CLVS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT